市场调查报告书
商品编码
1248100
美国宫内节育器(宫内节育器)市场:规模、副产品(铜宫内节育器、激素宫内节育器)、年龄组、行业分析报告、区域展望、增长潜力、竞争市场份额和预测,2023-2032 年U.S. Intrauterine Devices Market Size, By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 |
在美国,宫内节育器市场预计将在 2023 年至 2032 年之间增长,原因是对宫内节育器使用的认识有所提高,尤其是女性。
使用此类避孕药具可提高患者依从性,易于使用和维护,并可提高有效避孕率。
小型无焰铜和左炔诺孕酮释放装置,以及最近宫内节育技术的创新,可能有助于增加青少年和未婚女性对宫内节育器的使用。 此外,该国的一些政府和非政府组织正在努力提高人们对避孕药具(包括宫内节育器)重要性的认识,从而提高企业利润。
总体而言,美国宫内节育器行业按产品、年龄段和地区进行细分。
基于产品,含铜宫内节育器部分预计将在 2032 年出现显着增长。 宫内节育器已被证明可以避孕 10 年,并已证明其避孕效果超过 99%,并且有望在未来变得更加流行。
按年龄划分,预计 20-24 岁人群在 2023-2022 年的复合年增长率将超过 9.5%。 计划晚孕的成年女性越来越多地采用宫内节育器,这将在未来十年推动这一细分市场的增长。 此外,长期妊娠预防、安全有效宫内节育器的使用增加以及异位妊娠机率降低等变量可能会在估计的时期内加速该年龄组的产品采用。
预计从 2023 年到 2032 年,美国东北部的宫内节育器市场将出现显着增长。 该地区意外怀孕和相关健康危害的增加以及对有效避孕药具的日益偏好正在推动业务扩张。
此外,由于该地区的高堕胎率和医疗保健政策,住院率上升也将提振该行业的前景。 根据古特马赫研究所的预测,2020 年新泽西州进行了大约 48,830 例堕胎。 此外,中央政府针对青年开展的几项关于宫内避孕药和性健康的公众意识活动预计将进一步推动市场增长。
U.S. Intrauterine Devices Market is estimated to grow during 2023-2032 owing to an increasing awareness regarding the use of such devices, especially among the American female population. Implementation of such devices for birth control offers enhanced patient compliance, ease of use, and low maintenance, while increasing the rate of effective contraception.
Smaller frameless copper and levonorgestrel-releasing devices, along with recent innovations in intrauterine technology, may contribute to a rise in the usage of IUDs among teenagers and nulliparous women. Besides, several government and non-government organizations in the republic are also working on spreading awareness regarding the significance of contraceptive products, including IUDs, thus propelling the business revenue.
Overall, the U.S. intrauterine devices industry is segmented in terms of product, age group, and zone.
Based on the product, the copper IUD segment will exhibit considerable growth during 2032. A thin copper wire used in Copper's IUD loops around the "tstem." The IUD prevents conception for a period of ten years, proving to be more than 99% effective at preventing pregnancy, thus increasing its penetration in the years to come.
Considering the age, the 20-24 age group segment is anticipated to depict over 9.5% CAGR between 2023-2022. Increasing adoption of IUDs among adult women owing to planned delayed pregnancies will assist the segmental growth over the next 10 years. In addition, variables such as preventing pregnancy for a long time, increasing the availability of safe & effective intrauterine devices, and decreasing the chances of ectopic pregnancy will most likely accelerate the product adoption rate among this age group during the estimated timeframe.
Considering the zone, the Northeast U.S. intrauterine devices market will register strong gains during 2023-2032. A mounting number of unintended pregnancies and related health consequences coupled with the rising preference for highly effective contraceptive options in the zone will impel the business expansion.
Moreover, the increasing rate of hospitalization owing to the high incidences of abortion and supportive healthcare policies in the zone will also favor the industry outlook. According to the Guttmacher Institute projections, approximately 48,830 abortions took place in New Jersey in 2020. Moreover, several awareness initiatives taken by the central government for young adults concerning intrauterine devices and sexual health would further thrive the market growth substantially.